Tag: news

Categories
more
Tags
PARP inhibitorsOncologyovarian cancercoronaviruscoronovirusCompetitive IntelligenceRCCCOVID19NSCLCimmunotherapyHealthcare market researchbreast cancer

more
Current Posts
EU COVID-19 report cover
30.07.2020
Psyma Releases EU Survey Results on ...
US COVID-19 Impact Report
23.06.2020
Psyma Releases US Survey Results on ...
09.04.2020
It's Not Business As Usual
 more
Authors
James Roberts
Vice President,
Psyma International Inc.
Elly Simmons
Vice President, Strategy & Insights,
Psyma International Inc.
Richard Habis
Global Account Director Healthcare,
Psyma International Inc.
 more
Stay informed
Contact
Corporate Headquarters
Rückersdorf bei Nürnberg>
PSYMA GROUP AG
Fliedersteig 15 - 17
90607 Rückersdorf / Nürnberg
Germany
CONTACT REQUEST
SHOW LOCATIONS
Imprint | Privacy policy
copyright © 2023 PSYMA GROUP AG